Desert King® and the Vaccine Formulation Institute: A Strategic Alliance for Global Access to Vaccine Adjuvants
Desert King® (DK) and the Vaccine Formulation Institute (VFI) have joined forces in a strategic alliance to revolutionize global access to vaccine adjuvants.
Read More
Desert King® achieves EXCiPACT™ certification and strengthens its leadership in vaccine adjuvant production
Desert King®, a global leader in the vaccine adjuvant market based on Quillaja saponaria saponins, is proud to announce his EXCiPACT™ certification.
Read More
In vitro evaluation and molecular docking of QS-21 and quillaic acid from Quillaja saponaria Molina as gastric cancer agents
Abstract The cytotoxic mechanism of the saponin QS-21 and its aglycone quillaic acid (QA) was studied on human gastric cancer cells (SNU1 and KATO III). Both compounds sh...
Read More
Nano-scale quillaja extract can replicate fat for plant-based juiciness
Scientists are using Chilean quillaja extract to create nano-scale oleogels in plant-based proteins, mimicking the taste and texture of fat in meat and creating a ‘...
Read More
Benefits of Quillaja Saponaria for the Salmon Industry
“A safe, reliable, and natural solution for the salmon industry” After over five years of research collaboration between Desert King, leaders in the saponin m...
Read More
Notice from Las Vegas IFT 2017
19/07/2017 Mr. Ray Kramer for Foodnavigator.com http://www.foodnavigator.com/Ingredients/Emulsifiers-stabilisers-hydrocolloids/Desert-King-banks-on-plantations-for-sustai...
Read More